Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04923958Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network

Role: collaborator

NCT05941052Not ApplicableRecruiting

Assessing Diagnostics At Point-of-care for Tuberculosis

Role: collaborator

NCT04386083Unknown

Neurologic Manifestations of COVID-19

Role: collaborator

NCT01657318Terminated

Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers

Role: lead

NCT01421602Completed

A Prospective Observational Study on the Use of a Self Fixating Lightweight Polyester Mesh in Open Inguinal Hernia

Role: lead

All 5 trials loaded